Latest thinking
Regenerating ESG: Why FMCG brands need to go beyond sustainability
To stand out in the overcrowded ESG debate, FMCG companies should focus more on a proactive, positive impact rather than just doing less damage to the planet. The context: In recent years ESG has evolved into a cornerstone of PR efforts for FMCG companies. This has...
Recycling can soon become a reputational risk. Here’s what FMCG can do
As the concept of recycling is on the verge of a PR crisis, FMCG brands should refocus their ESG messaging. What's happening: We all do it. We purchase food and drink items, we see labels like "100% recyclable" or "100% recycled" on the plastic packaging, and our...
Pre-bunking: How pharma can combat misinformation on social
As healthcare communicators have struggled to combat statin misinformation with traditional debunking strategies, our study reveals how "pre-bunking" can be much more effective. The context: While statins - the most popular class of cholesterol-reducing drugs - are a...
Commetric wins 3 SABREs
Commetric is proud to announce its achievements at the SABRE EMEA Awards 2024, where it secured The SABRE Award for Superior Achievement in Measurement and Evaluation for its innovative collaboration with Novartis, alongside two IN2 SABRE Certificates of Excellence....
Relaunching the Commetric brand
An updated brand shows a new face, a new promise and an indication of real change for a business aiming to thrive in an evolving industry. All brand design work can be dismissed as ‘fluff’ for those who are inclined to think so. But for many who work in marketing,...
Gen AI means more reputation risk
PR veteran and Commetric co-founder Tony Burgess-Webb warns that today’s GenAI revolution is no time for comms professionals to stick their heads in the sand. Generative AI has captured everyone’s attention due to its ability to create text, images and video...
AI gets the axe? Tech giants grapple with messaging woes
Tech giants' layoff communications stumbled as they cited economic reasons that were at odds with their record earnings, inadvertently creating reputational risks by igniting concerns over AI's role in job cuts. What we found: As tech layoff announcements come in...
Reframing the drug pricing debate: how pharma can address media misconceptions
Reading time: 3 min As US drug pricing negotiations are making headlines every day, our analysis found that pharma's reputation is suffering mainly because of media misconceptions that companies can clear out. What we found: Our study of 1,705 English-language...
Novo Nordisk changed the obesity debate. But its reputation is on the line
Reading time: 3 min While Wegovy reshaped public attitudes about obesity, its maker Novo Nordisk oversaw critical reputational threats, highlighting that product success alone cannot safeguard pharma companies without a comprehensive, data-driven reputation management...